DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pataday (Olopatadine Hydrochloride Ophthalmic) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

Symptoms similar to cold syndrome and pharyngitis were reported at an incidence of approximately 10%.

The following adverse experiences have been reported in 5% or less of patients:

Ocular: blurred vision, burning or stinging, conjunctivitis, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, pain and ocular pruritus.

Non-ocular: asthenia, back pain, flu syndrome, headache, increased cough, infection, nausea, rhinitis, sinusitis and taste perversion.

Some of these events were similar to the underlying disease being studied.



REPORTS OF SUSPECTED PATADAY SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Pataday. The information is not vetted and should not be considered as verified clinical evidence.

Possible Pataday side effects / adverse reactions in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-02-21

Patient: 56 year old female weighing 63.5 kg (139.7 pounds)

Reactions: Eyelid Margin Crusting, Dyspnoea, Dysphagia, Oropharyngeal Pain, Cough

Suspect drug(s):
Pataday



Possible Pataday side effects / adverse reactions in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-06-05

Patient: 57 year old female weighing 90.7 kg (199.6 pounds)

Reactions: Back Pain, Lymphadenopathy, Dysphagia, Throat Irritation, Headache, Oropharyngeal Pain, Cough, Influenza Like Illness

Suspect drug(s):
Pataday
    Dosage: 1 drop 1x daily
    Indication: Eye Allergy
    Start date: 2012-05-18

Pataday
    Dosage: 1 drop 1x daily
    Indication: Eye Allergy
    Start date: 2012-05-21

Pataday
    Dosage: 1 drop 1x daily
    Indication: Eye Allergy
    Start date: 2012-05-20

Pataday
    Dosage: 1 drop 1x daily
    Indication: Eye Allergy
    Start date: 2012-05-19



Possible Pataday side effects / adverse reactions in 70 year old female

Reported by a physician from United States on 2012-08-03

Patient: 70 year old female

Reactions: Hypersensitivity, Rash Pruritic

Suspect drug(s):
Allegra
    Dosage: (60 mg)
    Indication: Product Used FOR Unknown Indication

Amaryl
    Dosage: 8 mg (4 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-08-03

Avandia
    Dosage: 8 mg (4 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-10-08

Celebrex
    Indication: Product Used FOR Unknown Indication

Daypro
    Indication: Product Used FOR Unknown Indication

Hydromorphone HCL
    Indication: Product Used FOR Unknown Indication

Lipitor
    Dosage: (20 mg)
    Indication: Product Used FOR Unknown Indication
    Start date: 2003-05-27

Metfformin Hydrochloride
    Dosage: 1000 mg (500 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-07-24

Mobic
    Dosage: (7.5 mg)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-18

Moxifloxacin HCL
    Indication: Product Used FOR Unknown Indication

Oxycodone HCL
    Indication: Product Used FOR Unknown Indication

Pataday
    Dosage: daily, ophthalmic
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-11-02

Pred-G
    Indication: Product Used FOR Unknown Indication

Promethazine
    Indication: Product Used FOR Unknown Indication

Promethazine
    Dosage: (12.5 mg), oral
    Administration route: Oral
    Indication: Nausea
    Start date: 2012-06-18

Systane (Rhinaris)
    Indication: Product Used FOR Unknown Indication

Vesicare
    Indication: Product Used FOR Unknown Indication

Vicodin
    Indication: Product Used FOR Unknown Indication



See index of all Pataday side effect reports >>

Drug label data at the top of this Page last updated: 2006-10-26

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012